Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
Clinical trial NCT03053050 · TERMINATED
Trial details
- NCT number
- NCT03053050
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-13
- Primary completion
- 2019-06-19
- Enrollment
- 808
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.